Skip to content

ELSA - Screening for type 1 diabetes in children

Early Surveillance for Autoimmune diabetes: the ELSA study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN97974414
Enrollment
50000
Registered
2024-06-17
Start date
2022-11-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes Nutritional, Metabolic, Endocrine

Interventions

The ELSA study is a screening programme to find out children’s risk of developing T1D. Families will be recruited from the community, including general practices, schools, and vaccination programmes.

Sponsors

University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children aged 3-13 years inclusive 2. Children of parents/guardians who consent to participation

Exclusion criteria

Exclusion criteria: 1. Children with a previous diagnosis of T1D 2. Children of parents/guardians who are unable/unwilling to consent to participation 3. Currently enrolled in any other screening programme for T1D 4. Where in the view of the PI, participation is not in the best interests of the child

Design outcomes

Primary

MeasureTime frame
1. Recruitment rate recorded as the number of eligible participants who consent to participate in the study by 24 months through online, primary care, school-based and other routes of recruitment 2. Acceptability of screening for diabetes as assessed by qualitative interviews with families and stakeholders at a single timepoint

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Contacts

Public ContactParth Narendran
p.narendran@bham.ac.uk+44 (0)121 414 3006

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026